specific form of DBM that includes a functional carrier, Glycerol USP, to support optimal surgical handling and implantation; can extend a smaller quantity of autograft than is normally required to achieve a solid spinal arthrodesis, consequently, a reduced amount of harvested autograft may be required, potentially diminishing the risk and severity of donor site complications